Acura Pharmaceuticals Pre-Tax Profit Margin 2010-2021 | ACUR
Acura Pharmaceuticals pre-tax profit margin from 2010 to 2021. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Acura Pharmaceuticals Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2021-12-31 |
$0.00B |
0 |
0.00% |
| 2021-09-30 |
$0.00B |
0 |
0.00% |
| 2021-06-30 |
$0.00B |
$0.00B |
-33.33% |
| 2021-03-31 |
$0.00B |
$0.00B |
-33.33% |
| 2020-12-31 |
$0.00B |
$0.00B |
-66.67% |
| 2020-09-30 |
$0.00B |
$0.00B |
-66.67% |
| 2020-06-30 |
$0.00B |
$0.00B |
-25.00% |
| 2020-03-31 |
$0.00B |
$0.00B |
-133.33% |
| 2019-12-31 |
$0.00B |
$0.00B |
-200.00% |
| 2019-09-30 |
$0.00B |
$0.00B |
-400.00% |
| 2019-06-30 |
$0.00B |
$-0.01B |
0.00% |
| 2019-03-31 |
$0.00B |
$0.00B |
0.00% |
| 2018-12-31 |
$0.00B |
$0.00B |
0.00% |
| 2018-09-30 |
$0.00B |
$-0.01B |
0.00% |
| 2018-06-30 |
$0.00B |
$-0.01B |
0.00% |
| 2018-03-31 |
$0.00B |
$-0.01B |
0.00% |
| 2017-12-31 |
$0.00B |
$-0.01B |
-200.00% |
| 2017-09-30 |
$0.01B |
$0.00B |
-28.57% |
| 2017-06-30 |
$0.01B |
$0.00B |
-28.57% |
| 2017-03-31 |
$0.01B |
$0.00B |
-42.86% |
| 2016-12-31 |
$0.00B |
$-0.01B |
-150.00% |
| 2016-09-30 |
$0.00B |
$-0.01B |
-300.00% |
| 2016-06-30 |
$0.00B |
$-0.01B |
-333.33% |
| 2016-03-31 |
$0.00B |
$-0.01B |
-333.33% |
| 2015-12-31 |
$0.01B |
$-0.01B |
-75.00% |
| 2015-09-30 |
$0.01B |
$-0.01B |
-133.33% |
| 2015-06-30 |
$0.01B |
$-0.01B |
-133.33% |
| 2015-03-31 |
$0.01B |
$-0.01B |
-150.00% |
| 2014-12-31 |
$0.00B |
$-0.01B |
-1400.00% |
| 2014-09-30 |
$0.00B |
$-0.01B |
0.00% |
| 2014-06-30 |
$0.00B |
$-0.01B |
0.00% |
| 2014-03-31 |
$0.00B |
$-0.01B |
0.00% |
| 2013-12-31 |
$0.00B |
$-0.01B |
0.00% |
| 2011-12-31 |
$0.02B |
$0.01B |
50.00% |
| 2011-06-30 |
$0.02B |
$0.01B |
40.00% |
| 2011-03-31 |
$0.00B |
$-0.01B |
-1200.00% |
| 2010-12-31 |
$0.00B |
$-0.01B |
-433.33% |
| 2010-09-30 |
$0.00B |
$-0.01B |
-350.00% |
| 2010-06-30 |
$0.01B |
$-0.02B |
-300.00% |
| 2010-03-31 |
$0.01B |
$-0.02B |
-300.00% |
| 2009-12-31 |
$0.00B |
$-0.01B |
-325.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.001B |
$0.000B |
|
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
|
